Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An 18-Week Randomized, Double-Blind, Multicenter, Comparator Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus

NCT00814294 is registered in ClinicalTrials.gov with Diasome Pharmaceuticals as lead sponsor.

NCT NCT00814294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00814294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An 18-Week Randomized, Double-Blind, Multicenter, Comparator Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus
Lead sponsor
Diasome Pharmaceuticals
Phase
Phase 2/3
Overall status
Completed
Start date
December 31, 2008
Completion date
September 30, 2009
Enrollment
239 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes